HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 06, June 2018 – Cancer - Therapies and strategies for better patient outcomes       » Gardasil 9 supply running short in Hong Kong       » China helps Tajikistan tackle grassland degradation       » Immuno-oncology trials in China surge more than 50 per cent       » Yeast for industrial biotechnology       » Uncontrolled hypertension in rural communities      
BIOBOARD - MALAYSIA
Marine bacterial compound shows antiviral potential
Scientists have obtained a compound with antiviral properties from marine bacteria found off the coast of New Ireland, Papua New Guinea.

The compound — antimycin A1a — displayed potent activity against a range of viruses, including the western equine encephalitis virus and RNA viruses from the Togaviridae family.

There are about 30 'alphaviruses' in the Togaviridae family that cause "significant diseases" in humans and animals all over the world, the study says. Encephalitic alphaviruses can kill up to 70 per cent of people they infect and leave most survivors with long-term neurological damage.

In their paper, the researchers note there are currently no licensed vaccines or antiviral drugs for alphavirus infections, resulting in a "pressing need" to identify new antiviral compounds.

The isolated compound is generated by a novel marine bacteria Streptomyces kaviengensis. In addition to displaying antiviral properties when tested on cultured cells, the compound was also able to reduce disease severity and enable the survival of some mice that had been infected with what is normally a lethal dose of western equine encephalitis virus.

The study received funding support from the National Institute of Allergy and Infectious Diseases, which is part of the United States' National Institutes of Health.

Principal investigator David Miller says the concept behind the research was to use the "ability of microorganisms to produce compounds of incredible and nearly limitless complexity" in the search for new drugs to treat viral infections similar to the way that many current antibiotics treat a wide range of infections.

Fatimah Md Yusoff, head of the Institute of Bioscience Laboratory of Marine Biotechnology at Putra University Malaysia, agrees that marine products offer great potential for drug discoveries.

"Marine natural products derived from plants — seaweeds, sea grasses and microalgae — and animals, especially invertebrates, fishes and microorganisms, have the potential to provide a vast array of chemical structures to be explored and discovered," she says. "These marine resources have great potential for antiviral drug development. But more studies are needed to understand not only their structure and effects, but also their effective antiviral application in humans."

Although antimycin A1a has shown antiviral activity in current tests, Miller was unable to give a timeline for drug development. He says the process takes years and is never certain.

"There are many steps involved and failure could occur at any of them," he says.

Zhen Yue
Source: Science Development Network

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy